Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 4 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025, Mar 2026, Apr 2026 and Jul 2026.
- Largest single sale: $5.0M (59,800 shares) of Dianthus Therapeutics, Inc. on Mar 31, 2026. Filing
- Last sale before this period: Sep 9, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Dianthus Therapeutics, Inc. (DNTH) | EVP, CFO & Cbo | Sep 13, 2023 | Jul 13, 2026 |
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jul 9, 2026, Dianthus Therapeutics, Inc.: sold 31,249 shares for $3.2M, under a disclosed plan; 31,249 shares acquired by exercising options. 1 filing: 1
- Apr 9, 2026, Dianthus Therapeutics, Inc.: sold 8,224 shares for $739K, under a disclosed plan; 8,224 shares acquired by exercising options. 1 filing: 1
- Mar 31, 2026, Dianthus Therapeutics, Inc.: sold 114,367 shares for $9.5M, under a disclosed plan; 114,367 shares acquired by exercising options. 1 filing: 1
- Dec 4, 2025, Dianthus Therapeutics, Inc.: sold 20,000 shares for $904K, under a disclosed plan; 20,000 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.